Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
26 Jul 2024 08:15 CEST |
BEKAERT | Bekaert - Mise à jour relative au Contrat de liquidité | 55102010 Iron and Steel | Legal |
26 Jul 2024 08:03 CEST |
NORTHERN OCEAN LTD. | NOTIFICATION OF MAJOR HOLDINGS | 60101030 Oil Equipment and Services | Major shareholding notifications |
26 Jul 2024 08:01 CEST |
MPC CONTAINER SHIPS | NOTIFICATION OF MAJOR HOLDINGS | 50206030 Marine Transportation | Major shareholding notifications |
26 Jul 2024 08:00 CEST |
SAS AB | SAS ger in månatliga finansiella rapporter till amerikansk domstol och offentliggör viss finansiell information för koncernen | 40501010 Airlines | Ikke-informasjonspliktige pressemeldinger |
26 Jul 2024 08:00 CEST |
CLARANOVA | Claranova renforce son équipe de direction pour accélérer l’amélioration de ses performances et développer son innovation | 10101015 Software | Journal / appointments |
26 Jul 2024 08:00 CEST |
SEGRO PUBLIC LIMITED COMPANY | SEGRO plc: Results for the Six Months Ended 30 June 2024 | 35102020 Industrial REITs | Other subject |
26 Jul 2024 08:00 CEST |
AIR FRANCE -KLM | description of the share buyback program 2024 | 40501010 Airlines | Other subject |
26 Jul 2024 08:00 CEST |
AMA CORPORATION PLC | AMA: 2024 first-half earnings | 50205020 Professional Business Support Services | General meeting / Board Meeting |
26 Jul 2024 08:00 CEST |
ACTICOR BIOTECH | Acticor Biotech Announces the Conclusions of the Interim Futility Analysis in the GREEN Study | 20103010 Biotechnology | Products and services |
26 Jul 2024 08:00 CEST |
ACTICOR BIOTECH | Acticor Biotech annonce les conclusions de l’analyse intermédiaire de futilité dans l’étude GREEN | 20103010 Biotechnology | Products and services |
26 Jul 2024 08:00 CEST |
AIR FRANCE -KLM | Descriptif du programme de rachat d'actions 2024 | 40501010 Airlines | Other subject |
26 Jul 2024 08:00 CEST |
AMA CORPORATION PLC | AMA : Chiffre d’affaires du 1er semestre 2024 | 50205020 Professional Business Support Services | General meeting / Board Meeting |
26 Jul 2024 08:00 CEST |
CRCAM TOURAINE CCI | Avis financier du 26/07/2024 | 30101010 Banks | Other subject |
26 Jul 2024 08:00 CEST |
CLARANOVA | Claranova Strengthens Its Executive Team to Accelerate Improved Performance and Drive Innovation | 10101015 Software | Journal / appointments |
26 Jul 2024 07:57 CEST |
GRAM CAR CARRIERS ASA | Compulsory acquisition - approval of guarantee | 50206030 Marine Transportation | Additional regulated information required to be disclosed under the laws of a Member State |
26 Jul 2024 07:34 CEST |
OVH | OVHcloud - Implementation of the share buyback programme | 10101010 Computer Services | Legal |
26 Jul 2024 07:34 CEST |
OVH | OVHcloud - Mise en oeuvre du programme de rachat d\'actions | 10101010 Computer Services | Legal |
26 Jul 2024 07:30 CEST |
FLOW TRADERS | Flow Traders 2Q 2024 Results | 30202015 Investment Services | Commercial results |
26 Jul 2024 07:30 CEST |
VALLOUREC | Vallourec Second Quarter 2024 Results | 60101030 Oil Equipment and Services | Income |
26 Jul 2024 07:30 CEST |
BOUYGUES | BOUYGUES: First-Half 2024 Results | 50101010 Construction | Income |
26 Jul 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
26 Jul 2024 07:30 CEST |
VALLOUREC | Vallourec : Résultats du Deuxième Trimestre 2024 | 60101030 Oil Equipment and Services | Income |
26 Jul 2024 07:30 CEST |
BOUYGUES | BOUYGUES : Résultats du premier semestre 2024 | 50101010 Construction | Income |
26 Jul 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
26 Jul 2024 07:20 CEST |
AIR LIQUIDE(L-) | Air Liquide: H1 2024 Results: Strong Margin Improvement and Major Projects to Prepare the Future | 55201020 Specialty Chemicals | Sales |
26 Jul 2024 07:20 CEST |
AIR LIQUIDE(L-) | Air Liquide : Résultats du 1er semestre 2024 : forte amélioration de la marge et projets majeurs pour préparer l’avenir | 55201020 Specialty Chemicals | Sales |
26 Jul 2024 07:05 CEST |
JINHUI SHIPPING AND TRANSPORTATION | MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDERS | 50206030 Marine Transportation | Mandatory notification of trade primary insiders |
26 Jul 2024 07:00 CEST |
AMUNDI | Amundi: First Half & Second Quarter 2024 results | 30202010 Asset Managers and Custodians | Commercial results |
26 Jul 2024 07:00 CEST |
AMUNDI | Amundi : Résultats du premier semestre & du deuxième trimestre 2024 | 30202010 Asset Managers and Custodians | Commercial results |
26 Jul 2024 07:00 CEST |
ACKERMANS V.HAAREN | Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge | 30202000 Diversified Financial Services | Income |
26 Jul 2024 07:00 CEST |
CAPGEMINI | Capgemini H1 2024 results | 10101010 Computer Services | Income |
26 Jul 2024 07:00 CEST |
BEKAERT | Bekaert: Résultats du premier semestre 2024 | 55102010 Iron and Steel | Sales |
26 Jul 2024 07:00 CEST |
VOPAK | Vopak reports continued strong results and announces capacity expansions in industrial terminals | 50206060 Transportation Services | Other subject |
26 Jul 2024 07:00 CEST |
UMICORE | UMICORE : RÉSULTATS DU PREMIER SEMESTRE 2024 | 55201020 Specialty Chemicals | Income |
26 Jul 2024 07:00 CEST |
ACKERMANS V.HAAREN | Ackermans & van Haaren leidt Serie B-financierings-ronde van 60 miljoen euro voor Confo Therapeutics, een Belgische biofarmaceutische onderneming | 30202000 Diversified Financial Services | Income |
26 Jul 2024 07:00 CEST |
CAPGEMINI | Capgemini : résultats du 1er semestre 2024 | 10101010 Computer Services | Income |
26 Jul 2024 07:00 CEST |
ACKERMANS V.HAAREN | Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company | 30202000 Diversified Financial Services | Income |
26 Jul 2024 07:00 CEST |
BEKAERT | Bekaert: Halfjaarresultaten 2024 | 55102010 Iron and Steel | Sales |
26 Jul 2024 07:00 CEST |
BEKAERT | Bekaert: 2024 Half Year Results | 55102010 Iron and Steel | Sales |
26 Jul 2024 07:00 CEST |
UMICORE | UMICORE: HALFJAARRESULTATEN 2024 | 55201020 Specialty Chemicals | Income |
26 Jul 2024 07:00 CEST |
SIGNIFY NV | Signify reports second quarter sales of EUR 1.5 billion, operational profitability of 7.9% and a free cash flow of EUR 51 million | 50101035 Building Materials: Other | Income |
26 Jul 2024 07:00 CEST |
UMICORE | UMICORE: HALF YEAR RESULTS 2024 | 55201020 Specialty Chemicals | Income |
26 Jul 2024 06:54 CEST |
SPIE | SPIE - Communiqué de presse - Résultats du 1er semestre 2024 | 50101015 Engineering and Contracting Services | Income |
26 Jul 2024 06:54 CEST |
SPIE | SPIE - Press release - 2024 Half-Year results | 50101015 Engineering and Contracting Services | Income |
26 Jul 2024 00:44 CEST |
NHOA | NHOA Group First Half 2024 Results and Q2 2024 Trading and Operational Update | 60102020 Renewable Energy Equipment | Other subject |
26 Jul 2024 00:44 CEST |
NHOA | RÉSULTATS DU GROUPE NHOA AU PREMIER SEMESTRE 2024 ET MISE À JOUR COMMERCIAL ET OPÉRATIONNELLE T2 2024 | 60102020 Renewable Energy Equipment | Other subject |
25 Jul 2024 23:20 CEST |
Cofina-SGPS | COFINA - SGPS, S.A. announces 1H2024 results | 40301030 Publishing | Other subject |
25 Jul 2024 23:20 CEST |
Cofina-SGPS | COFINA - SGPS, S.A. informa sobre Resultados do 1.º Semestre de 2024 | 40301030 Publishing | Other subject |
25 Jul 2024 22:44 CEST |
GOODTECH | Meldepliktig handel styret | 50202030 Electronic Equipment: Pollution Control | Meldepliktig handel for primærinnsidere |
25 Jul 2024 22:30 CEST |
CELLECTIS | La FDA accorde le statut de médicament orphelin et médicament pour une maladie pédiatrique rare (Rare Pediatric Disease Designation-RPDD) au produit candidat de Cellectis UCART22 pour le traitement de la leucémie lymphoblastique aiguë (LLA) | 20103010 Biotechnology | - |